nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—Premenstrual tension—Capecitabine—esophageal cancer	0.0453	0.0745	CcSEcCtD
Etonogestrel—Vulvovaginal pain—Capecitabine—esophageal cancer	0.0279	0.0459	CcSEcCtD
Etonogestrel—Vaginal pain—Capecitabine—esophageal cancer	0.0279	0.0459	CcSEcCtD
Etonogestrel—Premenstrual syndrome—Capecitabine—esophageal cancer	0.023	0.0378	CcSEcCtD
Etonogestrel—Fibrosis—Cisplatin—esophageal cancer	0.0179	0.0295	CcSEcCtD
Etonogestrel—Fibrosis—Capecitabine—esophageal cancer	0.0132	0.0217	CcSEcCtD
Etonogestrel—Varicose vein—Capecitabine—esophageal cancer	0.0101	0.0167	CcSEcCtD
Etonogestrel—Fibrosis—Methotrexate—esophageal cancer	0.00984	0.0162	CcSEcCtD
Etonogestrel—Pruritus genital—Capecitabine—esophageal cancer	0.00904	0.0149	CcSEcCtD
Etonogestrel—Generalised oedema—Cisplatin—esophageal cancer	0.00862	0.0142	CcSEcCtD
Etonogestrel—Depressed mood—Capecitabine—esophageal cancer	0.00845	0.0139	CcSEcCtD
Etonogestrel—Abscess—Cisplatin—esophageal cancer	0.00648	0.0106	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—NR1I2—esophageal cancer	0.00624	0.158	CrCbGaD
Etonogestrel—Infection—Carboplatin—esophageal cancer	0.00619	0.0102	CcSEcCtD
Etonogestrel—Nandrolone phenpropionate—CYP19A1—esophageal cancer	0.00619	0.157	CrCbGaD
Etonogestrel—Haematoma—Capecitabine—esophageal cancer	0.00601	0.00987	CcSEcCtD
Etonogestrel—Norgestimate—ABCC2—esophageal cancer	0.00542	0.137	CrCbGaD
Etonogestrel—Pain—Carboplatin—esophageal cancer	0.00533	0.00876	CcSEcCtD
Etonogestrel—Metrorrhagia—Capecitabine—esophageal cancer	0.00529	0.00869	CcSEcCtD
Etonogestrel—Hepatocellular injury—Cisplatin—esophageal cancer	0.00512	0.00842	CcSEcCtD
Etonogestrel—Body temperature increased—Carboplatin—esophageal cancer	0.00493	0.0081	CcSEcCtD
Etonogestrel—Fluid retention—Cisplatin—esophageal cancer	0.00487	0.00799	CcSEcCtD
Etonogestrel—Otitis media—Capecitabine—esophageal cancer	0.00485	0.00797	CcSEcCtD
Etonogestrel—Nandrolone decanoate—CYP19A1—esophageal cancer	0.00469	0.119	CrCbGaD
Etonogestrel—Injection site pain—Capecitabine—esophageal cancer	0.00463	0.0076	CcSEcCtD
Etonogestrel—Vaginal discharge—Methotrexate—esophageal cancer	0.00462	0.00759	CcSEcCtD
Etonogestrel—Contusion—Capecitabine—esophageal cancer	0.00433	0.00711	CcSEcCtD
Etonogestrel—Liver disorder—Methotrexate—esophageal cancer	0.00413	0.00678	CcSEcCtD
Etonogestrel—Herpes simplex—Capecitabine—esophageal cancer	0.0041	0.00673	CcSEcCtD
Etonogestrel—Bone pain—Capecitabine—esophageal cancer	0.00394	0.00648	CcSEcCtD
Etonogestrel—Blood pressure increased—Capecitabine—esophageal cancer	0.00378	0.00621	CcSEcCtD
Etonogestrel—Injection site reaction—Capecitabine—esophageal cancer	0.00376	0.00617	CcSEcCtD
Etonogestrel—Influenza like illness—Capecitabine—esophageal cancer	0.00367	0.00603	CcSEcCtD
Etonogestrel—Fluid retention—Capecitabine—esophageal cancer	0.00359	0.00589	CcSEcCtD
Etonogestrel—Abscess—Methotrexate—esophageal cancer	0.00355	0.00584	CcSEcCtD
Etonogestrel—Irritability—Cisplatin—esophageal cancer	0.00355	0.00583	CcSEcCtD
Etonogestrel—Neoplasm—Capecitabine—esophageal cancer	0.00342	0.00561	CcSEcCtD
Etonogestrel—Breast disorder—Cisplatin—esophageal cancer	0.00336	0.00552	CcSEcCtD
Etonogestrel—Cramp muscle—Cisplatin—esophageal cancer	0.00335	0.0055	CcSEcCtD
Etonogestrel—Abnormal vision—Capecitabine—esophageal cancer	0.00329	0.00541	CcSEcCtD
Etonogestrel—Levonorgestrel—CYP19A1—esophageal cancer	0.00312	0.0789	CrCbGaD
Etonogestrel—Swelling—Capecitabine—esophageal cancer	0.00311	0.00511	CcSEcCtD
Etonogestrel—Herpes simplex—Methotrexate—esophageal cancer	0.00305	0.00501	CcSEcCtD
Etonogestrel—Libido decreased—Capecitabine—esophageal cancer	0.00296	0.00486	CcSEcCtD
Etonogestrel—Hot flush—Capecitabine—esophageal cancer	0.00293	0.00482	CcSEcCtD
Etonogestrel—Increased appetite—Capecitabine—esophageal cancer	0.00292	0.0048	CcSEcCtD
Etonogestrel—Menopausal symptoms—Capecitabine—esophageal cancer	0.00291	0.00477	CcSEcCtD
Etonogestrel—Danazol—CYP19A1—esophageal cancer	0.00284	0.0719	CrCbGaD
Etonogestrel—Vaginal inflammation—Methotrexate—esophageal cancer	0.00281	0.00462	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00281	0.00462	CcSEcCtD
Etonogestrel—Ethinyl Estradiol—ABCC2—esophageal cancer	0.0028	0.0707	CrCbGaD
Etonogestrel—Cystitis noninfective—Methotrexate—esophageal cancer	0.00275	0.00451	CcSEcCtD
Etonogestrel—Pain in extremity—Capecitabine—esophageal cancer	0.00274	0.00451	CcSEcCtD
Etonogestrel—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00272	0.00447	CcSEcCtD
Etonogestrel—Cystitis—Methotrexate—esophageal cancer	0.00272	0.00446	CcSEcCtD
Etonogestrel—Migraine—Capecitabine—esophageal cancer	0.0027	0.00443	CcSEcCtD
Etonogestrel—Vaginal infection—Methotrexate—esophageal cancer	0.00265	0.00436	CcSEcCtD
Etonogestrel—Irritability—Capecitabine—esophageal cancer	0.00262	0.0043	CcSEcCtD
Etonogestrel—Mood swings—Capecitabine—esophageal cancer	0.0026	0.00427	CcSEcCtD
Etonogestrel—Neoplasm—Methotrexate—esophageal cancer	0.00254	0.00418	CcSEcCtD
Etonogestrel—Bladder pain—Methotrexate—esophageal cancer	0.00254	0.00418	CcSEcCtD
Etonogestrel—Urinary tract disorder—Cisplatin—esophageal cancer	0.00254	0.00418	CcSEcCtD
Etonogestrel—Connective tissue disorder—Cisplatin—esophageal cancer	0.00253	0.00415	CcSEcCtD
Etonogestrel—Urethral disorder—Cisplatin—esophageal cancer	0.00252	0.00414	CcSEcCtD
Etonogestrel—Visual impairment—Cisplatin—esophageal cancer	0.00248	0.00407	CcSEcCtD
Etonogestrel—Breast disorder—Capecitabine—esophageal cancer	0.00248	0.00407	CcSEcCtD
Etonogestrel—Gastritis—Capecitabine—esophageal cancer	0.00243	0.00399	CcSEcCtD
Etonogestrel—Eye disorder—Cisplatin—esophageal cancer	0.0024	0.00395	CcSEcCtD
Etonogestrel—Methyltestosterone—CYP19A1—esophageal cancer	0.0024	0.0607	CrCbGaD
Etonogestrel—Abdominal distension—Capecitabine—esophageal cancer	0.00239	0.00392	CcSEcCtD
Etonogestrel—Asthma—Capecitabine—esophageal cancer	0.00237	0.00389	CcSEcCtD
Etonogestrel—Immune system disorder—Cisplatin—esophageal cancer	0.00232	0.00382	CcSEcCtD
Etonogestrel—Bronchitis—Capecitabine—esophageal cancer	0.00228	0.00374	CcSEcCtD
Etonogestrel—Alopecia—Cisplatin—esophageal cancer	0.00227	0.00374	CcSEcCtD
Etonogestrel—Erythema—Cisplatin—esophageal cancer	0.00224	0.00368	CcSEcCtD
Etonogestrel—Malnutrition—Cisplatin—esophageal cancer	0.00224	0.00368	CcSEcCtD
Etonogestrel—Dysuria—Capecitabine—esophageal cancer	0.00222	0.00364	CcSEcCtD
Etonogestrel—Flatulence—Cisplatin—esophageal cancer	0.00221	0.00363	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.0022	0.00362	CcSEcCtD
Etonogestrel—Weight increased—Capecitabine—esophageal cancer	0.00216	0.00354	CcSEcCtD
Etonogestrel—Visual disturbance—Methotrexate—esophageal cancer	0.00215	0.00354	CcSEcCtD
Etonogestrel—Muscle spasms—Cisplatin—esophageal cancer	0.00215	0.00354	CcSEcCtD
Etonogestrel—Weight decreased—Capecitabine—esophageal cancer	0.00214	0.00352	CcSEcCtD
Etonogestrel—Infestation—Capecitabine—esophageal cancer	0.00211	0.00347	CcSEcCtD
Etonogestrel—Infestation NOS—Capecitabine—esophageal cancer	0.00211	0.00347	CcSEcCtD
Etonogestrel—Depression—Capecitabine—esophageal cancer	0.00211	0.00346	CcSEcCtD
Etonogestrel—Ill-defined disorder—Cisplatin—esophageal cancer	0.00208	0.00341	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00207	0.0034	CcSEcCtD
Etonogestrel—Urinary tract infection—Capecitabine—esophageal cancer	0.00205	0.00337	CcSEcCtD
Etonogestrel—Malaise—Cisplatin—esophageal cancer	0.00202	0.00332	CcSEcCtD
Etonogestrel—Irritability—Methotrexate—esophageal cancer	0.00195	0.0032	CcSEcCtD
Etonogestrel—Convulsion—Cisplatin—esophageal cancer	0.00194	0.00319	CcSEcCtD
Etonogestrel—Mood swings—Methotrexate—esophageal cancer	0.00193	0.00318	CcSEcCtD
Etonogestrel—Myalgia—Cisplatin—esophageal cancer	0.00191	0.00313	CcSEcCtD
Etonogestrel—Haemoglobin—Capecitabine—esophageal cancer	0.00191	0.00313	CcSEcCtD
Etonogestrel—Rhinitis—Capecitabine—esophageal cancer	0.0019	0.00312	CcSEcCtD
Etonogestrel—Anxiety—Cisplatin—esophageal cancer	0.0019	0.00312	CcSEcCtD
Etonogestrel—Testosterone—CYP1B1—esophageal cancer	0.0019	0.048	CrCbGaD
Etonogestrel—Haemorrhage—Capecitabine—esophageal cancer	0.0019	0.00312	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00189	0.00311	CcSEcCtD
Etonogestrel—Hypoaesthesia—Capecitabine—esophageal cancer	0.00189	0.0031	CcSEcCtD
Etonogestrel—Discomfort—Cisplatin—esophageal cancer	0.00188	0.0031	CcSEcCtD
Etonogestrel—Pharyngitis—Capecitabine—esophageal cancer	0.00188	0.00309	CcSEcCtD
Etonogestrel—Urinary tract disorder—Capecitabine—esophageal cancer	0.00187	0.00308	CcSEcCtD
Etonogestrel—Connective tissue disorder—Capecitabine—esophageal cancer	0.00186	0.00306	CcSEcCtD
Etonogestrel—Urethral disorder—Capecitabine—esophageal cancer	0.00186	0.00306	CcSEcCtD
Etonogestrel—Breast disorder—Methotrexate—esophageal cancer	0.00184	0.00303	CcSEcCtD
Etonogestrel—Oedema—Cisplatin—esophageal cancer	0.00183	0.003	CcSEcCtD
Etonogestrel—Anaphylactic shock—Cisplatin—esophageal cancer	0.00183	0.003	CcSEcCtD
Etonogestrel—Visual impairment—Capecitabine—esophageal cancer	0.00183	0.003	CcSEcCtD
Etonogestrel—Infection—Cisplatin—esophageal cancer	0.00182	0.00298	CcSEcCtD
Etonogestrel—Nervous system disorder—Cisplatin—esophageal cancer	0.00179	0.00295	CcSEcCtD
Etonogestrel—Skin disorder—Cisplatin—esophageal cancer	0.00178	0.00292	CcSEcCtD
Etonogestrel—Eye disorder—Capecitabine—esophageal cancer	0.00177	0.00291	CcSEcCtD
Etonogestrel—Asthma—Methotrexate—esophageal cancer	0.00176	0.0029	CcSEcCtD
Etonogestrel—Anorexia—Cisplatin—esophageal cancer	0.00174	0.00286	CcSEcCtD
Etonogestrel—Angiopathy—Capecitabine—esophageal cancer	0.00172	0.00283	CcSEcCtD
Etonogestrel—Immune system disorder—Capecitabine—esophageal cancer	0.00171	0.00282	CcSEcCtD
Etonogestrel—Alopecia—Capecitabine—esophageal cancer	0.00168	0.00275	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00167	0.00274	CcSEcCtD
Etonogestrel—Mental disorder—Capecitabine—esophageal cancer	0.00166	0.00273	CcSEcCtD
Etonogestrel—Malnutrition—Capecitabine—esophageal cancer	0.00165	0.00271	CcSEcCtD
Etonogestrel—Erythema—Capecitabine—esophageal cancer	0.00165	0.00271	CcSEcCtD
Etonogestrel—Dysuria—Methotrexate—esophageal cancer	0.00165	0.00271	CcSEcCtD
Etonogestrel—Paraesthesia—Cisplatin—esophageal cancer	0.00164	0.0027	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00164	0.00269	CcSEcCtD
Etonogestrel—Flatulence—Capecitabine—esophageal cancer	0.00163	0.00267	CcSEcCtD
Etonogestrel—Back pain—Capecitabine—esophageal cancer	0.0016	0.00262	CcSEcCtD
Etonogestrel—Decreased appetite—Cisplatin—esophageal cancer	0.00159	0.00261	CcSEcCtD
Etonogestrel—Muscle spasms—Capecitabine—esophageal cancer	0.00159	0.00261	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00158	0.00259	CcSEcCtD
Etonogestrel—Infestation NOS—Methotrexate—esophageal cancer	0.00157	0.00258	CcSEcCtD
Etonogestrel—Infestation—Methotrexate—esophageal cancer	0.00157	0.00258	CcSEcCtD
Etonogestrel—Depression—Methotrexate—esophageal cancer	0.00157	0.00258	CcSEcCtD
Etonogestrel—Pain—Cisplatin—esophageal cancer	0.00156	0.00257	CcSEcCtD
Etonogestrel—Ill-defined disorder—Capecitabine—esophageal cancer	0.00153	0.00252	CcSEcCtD
Etonogestrel—Feeling abnormal—Cisplatin—esophageal cancer	0.00151	0.00248	CcSEcCtD
Etonogestrel—Malaise—Capecitabine—esophageal cancer	0.00149	0.00245	CcSEcCtD
Etonogestrel—Body temperature increased—Cisplatin—esophageal cancer	0.00145	0.00237	CcSEcCtD
Etonogestrel—Cough—Capecitabine—esophageal cancer	0.00144	0.00237	CcSEcCtD
Etonogestrel—Hypertension—Capecitabine—esophageal cancer	0.00143	0.00234	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—esophageal cancer	0.00142	0.00233	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—esophageal cancer	0.00141	0.00232	CcSEcCtD
Etonogestrel—Arthralgia—Capecitabine—esophageal cancer	0.00141	0.00231	CcSEcCtD
Etonogestrel—Myalgia—Capecitabine—esophageal cancer	0.00141	0.00231	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—esophageal cancer	0.0014	0.0023	CcSEcCtD
Etonogestrel—Anxiety—Capecitabine—esophageal cancer	0.0014	0.0023	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.0014	0.00229	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—esophageal cancer	0.00139	0.00229	CcSEcCtD
Etonogestrel—Testosterone—CYP19A1—esophageal cancer	0.00139	0.0352	CrCbGaD
Etonogestrel—Discomfort—Capecitabine—esophageal cancer	0.00139	0.00228	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—esophageal cancer	0.00138	0.00227	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—esophageal cancer	0.00136	0.00224	CcSEcCtD
Etonogestrel—Oedema—Capecitabine—esophageal cancer	0.00135	0.00221	CcSEcCtD
Etonogestrel—Hypersensitivity—Cisplatin—esophageal cancer	0.00135	0.00221	CcSEcCtD
Etonogestrel—Infection—Capecitabine—esophageal cancer	0.00134	0.0022	CcSEcCtD
Etonogestrel—Nervous system disorder—Capecitabine—esophageal cancer	0.00132	0.00217	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—esophageal cancer	0.00132	0.00217	CcSEcCtD
Etonogestrel—Asthenia—Cisplatin—esophageal cancer	0.00131	0.00216	CcSEcCtD
Etonogestrel—Skin disorder—Capecitabine—esophageal cancer	0.00131	0.00215	CcSEcCtD
Etonogestrel—Anorexia—Capecitabine—esophageal cancer	0.00128	0.00211	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—esophageal cancer	0.00128	0.0021	CcSEcCtD
Etonogestrel—Immune system disorder—Methotrexate—esophageal cancer	0.00128	0.0021	CcSEcCtD
Etonogestrel—Diarrhoea—Cisplatin—esophageal cancer	0.00125	0.00206	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—esophageal cancer	0.00125	0.00205	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—esophageal cancer	0.00124	0.00203	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—esophageal cancer	0.00123	0.00202	CcSEcCtD
Etonogestrel—Malnutrition—Methotrexate—esophageal cancer	0.00123	0.00202	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00123	0.00202	CcSEcCtD
Etonogestrel—Insomnia—Capecitabine—esophageal cancer	0.00122	0.002	CcSEcCtD
Etonogestrel—Paraesthesia—Capecitabine—esophageal cancer	0.00121	0.00199	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—esophageal cancer	0.00119	0.00195	CcSEcCtD
Etonogestrel—Dyspepsia—Capecitabine—esophageal cancer	0.00119	0.00195	CcSEcCtD
Etonogestrel—Decreased appetite—Capecitabine—esophageal cancer	0.00117	0.00192	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00116	0.00191	CcSEcCtD
Etonogestrel—Vomiting—Cisplatin—esophageal cancer	0.00116	0.00191	CcSEcCtD
Etonogestrel—Fatigue—Capecitabine—esophageal cancer	0.00116	0.00191	CcSEcCtD
Etonogestrel—Rash—Cisplatin—esophageal cancer	0.00115	0.00189	CcSEcCtD
Etonogestrel—Pain—Capecitabine—esophageal cancer	0.00115	0.00189	CcSEcCtD
Etonogestrel—Constipation—Capecitabine—esophageal cancer	0.00115	0.00189	CcSEcCtD
Etonogestrel—Dermatitis—Cisplatin—esophageal cancer	0.00115	0.00189	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—esophageal cancer	0.00114	0.00187	CcSEcCtD
Etonogestrel—Feeling abnormal—Capecitabine—esophageal cancer	0.00111	0.00182	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—EP300—esophageal cancer	0.00111	0.00316	CbGpPWpGaD
Etonogestrel—Malaise—Methotrexate—esophageal cancer	0.00111	0.00182	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.0011	0.00313	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Capecitabine—esophageal cancer	0.0011	0.00181	CcSEcCtD
Etonogestrel—Nausea—Cisplatin—esophageal cancer	0.00109	0.00178	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.00109	0.00308	CbGpPWpGaD
Etonogestrel—Cough—Methotrexate—esophageal cancer	0.00107	0.00176	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—BCL2—esophageal cancer	0.00107	0.00304	CbGpPWpGaD
Etonogestrel—Urticaria—Capecitabine—esophageal cancer	0.00107	0.00176	CcSEcCtD
Etonogestrel—ESR1—FOXA1 transcription factor network—EP300—esophageal cancer	0.00107	0.00304	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CHEK2—esophageal cancer	0.00107	0.00304	CbGpPWpGaD
Etonogestrel—Abdominal pain—Capecitabine—esophageal cancer	0.00107	0.00175	CcSEcCtD
Etonogestrel—Body temperature increased—Capecitabine—esophageal cancer	0.00107	0.00175	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—esophageal cancer	0.00107	0.00175	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—esophageal cancer	0.00105	0.00172	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—esophageal cancer	0.00105	0.00172	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00104	0.00171	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—esophageal cancer	0.00103	0.0017	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.00103	0.00294	CbGpPWpGaD
Etonogestrel—Ethinyl Estradiol—ABCB1—esophageal cancer	0.00103	0.026	CrCbGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00102	0.00291	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00102	0.00289	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Methotrexate—esophageal cancer	0.001	0.00165	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CYP19A1—esophageal cancer	0.001	0.00284	CbGpPWpGaD
Etonogestrel—Infection—Methotrexate—esophageal cancer	0.000997	0.00164	CcSEcCtD
Etonogestrel—Hypersensitivity—Capecitabine—esophageal cancer	0.000993	0.00163	CcSEcCtD
Etonogestrel—Norethindrone—ABCB1—esophageal cancer	0.000989	0.025	CrCbGaD
Etonogestrel—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000989	0.00281	CbGpPWpGaD
Etonogestrel—Nervous system disorder—Methotrexate—esophageal cancer	0.000984	0.00162	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—esophageal cancer	0.000975	0.0016	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—MYC—esophageal cancer	0.000968	0.00275	CbGpPWpGaD
Etonogestrel—Asthenia—Capecitabine—esophageal cancer	0.000967	0.00159	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.000964	0.00274	CbGpPWpGaD
Etonogestrel—Anorexia—Methotrexate—esophageal cancer	0.000956	0.00157	CcSEcCtD
Etonogestrel—Pruritus—Capecitabine—esophageal cancer	0.000954	0.00157	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—MYC—esophageal cancer	0.00095	0.0027	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.000949	0.0027	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000942	0.00268	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00093	0.00264	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TGFBR2—esophageal cancer	0.000926	0.00263	CbGpPWpGaD
Etonogestrel—Diarrhoea—Capecitabine—esophageal cancer	0.000922	0.00152	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	0.000919	0.00261	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CCND1—esophageal cancer	0.000919	0.00261	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—NOS3—esophageal cancer	0.000918	0.00261	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000914	0.0015	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—GDI2—esophageal cancer	0.000911	0.00259	CbGpPWpGaD
Etonogestrel—Insomnia—Methotrexate—esophageal cancer	0.000907	0.00149	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.000905	0.00257	CbGpPWpGaD
Etonogestrel—Paraesthesia—Methotrexate—esophageal cancer	0.000901	0.00148	CcSEcCtD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000901	0.00256	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.0009	0.00256	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000898	0.00255	CbGpPWpGaD
Etonogestrel—Somnolence—Methotrexate—esophageal cancer	0.000892	0.00147	CcSEcCtD
Etonogestrel—Dizziness—Capecitabine—esophageal cancer	0.000891	0.00146	CcSEcCtD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000889	0.00253	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000885	0.00252	CbGpPWpGaD
Etonogestrel—Dyspepsia—Methotrexate—esophageal cancer	0.000883	0.00145	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00088	0.0025	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.000876	0.00249	CbGpPWpGaD
Etonogestrel—Decreased appetite—Methotrexate—esophageal cancer	0.000872	0.00143	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000866	0.00142	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—esophageal cancer	0.000865	0.00142	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—esophageal cancer	0.000861	0.00245	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—ERBB2—esophageal cancer	0.000859	0.00244	CbGpPWpGaD
Etonogestrel—Pain—Methotrexate—esophageal cancer	0.000858	0.00141	CcSEcCtD
Etonogestrel—Vomiting—Capecitabine—esophageal cancer	0.000857	0.00141	CcSEcCtD
Etonogestrel—Rash—Capecitabine—esophageal cancer	0.00085	0.0014	CcSEcCtD
Etonogestrel—Dermatitis—Capecitabine—esophageal cancer	0.000849	0.00139	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—EP300—esophageal cancer	0.000846	0.00241	CbGpPWpGaD
Etonogestrel—Headache—Capecitabine—esophageal cancer	0.000844	0.00139	CcSEcCtD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000844	0.0024	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—esophageal cancer	0.000837	0.00238	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—ERBB2—esophageal cancer	0.000831	0.00236	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.000829	0.00236	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Methotrexate—esophageal cancer	0.000827	0.00136	CcSEcCtD
Etonogestrel—PGR—Gene Expression—SMG6—esophageal cancer	0.000826	0.00235	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—CCND1—esophageal cancer	0.000821	0.00233	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00082	0.00135	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000816	0.00232	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CCND1—esophageal cancer	0.000802	0.00228	CbGpPWpGaD
Etonogestrel—Nausea—Capecitabine—esophageal cancer	0.000801	0.00132	CcSEcCtD
Etonogestrel—Urticaria—Methotrexate—esophageal cancer	0.000797	0.00131	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—esophageal cancer	0.000793	0.0013	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—esophageal cancer	0.000793	0.0013	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—esophageal cancer	0.000793	0.00225	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—TP53—esophageal cancer	0.00078	0.00222	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000777	0.00221	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000763	0.00217	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—CCND1—esophageal cancer	0.000759	0.00216	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.00075	0.00213	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Methotrexate—esophageal cancer	0.000739	0.00121	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—EP300—esophageal cancer	0.000738	0.0021	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000732	0.00208	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00073	0.00208	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000726	0.00206	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000726	0.00206	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000726	0.00206	CbGpPWpGaD
Etonogestrel—Asthenia—Methotrexate—esophageal cancer	0.00072	0.00118	CcSEcCtD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000716	0.00204	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—CDKN1A—esophageal cancer	0.000711	0.00202	CbGpPWpGaD
Etonogestrel—Pruritus—Methotrexate—esophageal cancer	0.00071	0.00117	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000692	0.00197	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—esophageal cancer	0.000691	0.00196	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.00069	0.00196	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000687	0.00195	CbGpPWpGaD
Etonogestrel—Diarrhoea—Methotrexate—esophageal cancer	0.000686	0.00113	CcSEcCtD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000683	0.00194	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000674	0.00191	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000668	0.0019	CbGpPWpGaD
Etonogestrel—Dizziness—Methotrexate—esophageal cancer	0.000663	0.00109	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—KMT2D—esophageal cancer	0.000659	0.00187	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—esophageal cancer	0.000658	0.00187	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000657	0.00187	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—EGFR—esophageal cancer	0.000644	0.00183	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—esophageal cancer	0.000643	0.00183	CbGpPWpGaD
Etonogestrel—Vomiting—Methotrexate—esophageal cancer	0.000638	0.00105	CcSEcCtD
Etonogestrel—Rash—Methotrexate—esophageal cancer	0.000633	0.00104	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—esophageal cancer	0.000632	0.00104	CcSEcCtD
Etonogestrel—Headache—Methotrexate—esophageal cancer	0.000629	0.00103	CcSEcCtD
Etonogestrel—PGR—Gene Expression—NR1I2—esophageal cancer	0.000626	0.00178	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000615	0.00175	CbGpPWpGaD
Etonogestrel—Nausea—Methotrexate—esophageal cancer	0.000596	0.000979	CcSEcCtD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000589	0.00167	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000588	0.00167	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ADCYAP1—esophageal cancer	0.000587	0.00167	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000586	0.00166	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000584	0.00166	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—esophageal cancer	0.000576	0.00164	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000572	0.00163	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000553	0.00157	CbGpPWpGaD
Etonogestrel—Testosterone—ABCB1—esophageal cancer	0.000545	0.0138	CrCbGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000544	0.00155	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—HIST1H2BM—esophageal cancer	0.000537	0.00153	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000537	0.00153	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—WWOX—esophageal cancer	0.000537	0.00153	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GDI2—esophageal cancer	0.000535	0.00152	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—esophageal cancer	0.000528	0.0015	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FKBP1A—esophageal cancer	0.000511	0.00145	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000506	0.00144	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000505	0.00144	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—PIK3CA—esophageal cancer	0.0005	0.00142	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000499	0.00142	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—WIF1—esophageal cancer	0.000499	0.00142	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—ERBB2—esophageal cancer	0.000488	0.00139	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000488	0.00139	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000485	0.00138	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SMG6—esophageal cancer	0.000485	0.00138	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000479	0.00136	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CSNK1A1—esophageal cancer	0.000461	0.00131	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000453	0.00129	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000433	0.00123	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PFN1—esophageal cancer	0.000431	0.00122	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.00043	0.00122	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000418	0.00119	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CDKN1A—esophageal cancer	0.000417	0.00119	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PSME1—esophageal cancer	0.000416	0.00118	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PSME2—esophageal cancer	0.000416	0.00118	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000413	0.00117	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000411	0.00117	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000407	0.00116	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000399	0.00113	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000397	0.00113	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH3—esophageal cancer	0.000393	0.00112	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000392	0.00112	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000388	0.0011	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ELMO1—esophageal cancer	0.000387	0.0011	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KMT2D—esophageal cancer	0.000387	0.0011	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—AKAP13—esophageal cancer	0.000378	0.00108	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000368	0.00105	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR1I2—esophageal cancer	0.000367	0.00104	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000361	0.00103	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000359	0.00102	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH2—esophageal cancer	0.000352	0.001	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000349	0.000992	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	0.000348	0.000988	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000347	0.000988	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDE4D—esophageal cancer	0.000346	0.000983	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000344	0.000979	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	0.00034	0.000967	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—esophageal cancer	0.000338	0.000962	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000331	0.00094	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GNG7—esophageal cancer	0.000329	0.000935	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—HIST1H2BM—esophageal cancer	0.000315	0.000896	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—WWOX—esophageal cancer	0.000315	0.000896	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000313	0.000889	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000308	0.000877	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—XIAP—esophageal cancer	0.000308	0.000877	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FKBP1A—esophageal cancer	0.0003	0.000852	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—SMAD4—esophageal cancer	0.000296	0.000841	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000294	0.000836	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PIK3CA—esophageal cancer	0.000294	0.000835	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—WIF1—esophageal cancer	0.000293	0.000833	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNA1—esophageal cancer	0.000292	0.000829	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00029	0.000824	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL2—esophageal cancer	0.00029	0.000824	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000288	0.000819	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	0.000286	0.000812	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000282	0.000801	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PSME1—esophageal cancer	0.000271	0.00077	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PSME2—esophageal cancer	0.000271	0.00077	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CSNK1A1—esophageal cancer	0.00027	0.000768	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ANXA1—esophageal cancer	0.00027	0.000766	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000266	0.000756	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SST—esophageal cancer	0.000262	0.000745	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH3—esophageal cancer	0.000255	0.000726	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GHRL—esophageal cancer	0.000255	0.000726	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PFN1—esophageal cancer	0.000253	0.000719	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FBXW7—esophageal cancer	0.000251	0.000715	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000245	0.000695	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PSME1—esophageal cancer	0.000244	0.000695	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PSME2—esophageal cancer	0.000244	0.000695	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—esophageal cancer	0.000244	0.000693	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000241	0.000685	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000237	0.000673	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH3—esophageal cancer	0.000231	0.000656	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH2—esophageal cancer	0.000229	0.000651	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ELMO1—esophageal cancer	0.000227	0.000646	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—AKAP13—esophageal cancer	0.000222	0.000631	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NOTCH1—esophageal cancer	0.000218	0.00062	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH2—esophageal cancer	0.000207	0.000588	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000205	0.000582	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TGFBR2—esophageal cancer	0.000203	0.000578	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDE4D—esophageal cancer	0.000203	0.000577	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CREBBP—esophageal cancer	0.000198	0.000562	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GNG7—esophageal cancer	0.000193	0.000549	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SMAD4—esophageal cancer	0.000192	0.000547	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—XIAP—esophageal cancer	0.000181	0.000514	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SMAD4—esophageal cancer	0.000174	0.000494	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	0.000171	0.000486	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL2—esophageal cancer	0.00017	0.000484	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PSME1—esophageal cancer	0.000159	0.000452	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PSME2—esophageal cancer	0.000159	0.000452	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ANXA1—esophageal cancer	0.000158	0.00045	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000158	0.000449	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000158	0.000449	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HIF1A—esophageal cancer	0.000157	0.000448	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SST—esophageal cancer	0.000154	0.000437	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KDR—esophageal cancer	0.000151	0.000428	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	0.00015	0.000426	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GHRL—esophageal cancer	0.00015	0.000426	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FBXW7—esophageal cancer	0.000148	0.000419	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	0.000143	0.000407	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOTCH1—esophageal cancer	0.000142	0.000403	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	0.000134	0.000382	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA1—esophageal cancer	0.000134	0.000382	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000134	0.000382	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CREBBP—esophageal cancer	0.000129	0.000366	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NOTCH1—esophageal cancer	0.000128	0.000364	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA2—esophageal cancer	0.000123	0.000349	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	0.000119	0.000339	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—esophageal cancer	0.000117	0.000334	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CREBBP—esophageal cancer	0.000116	0.00033	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOS3—esophageal cancer	0.000115	0.000327	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000114	0.000325	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000114	0.000325	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SMAD4—esophageal cancer	0.000113	0.000321	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB2—esophageal cancer	0.000108	0.000306	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.0001	0.000285	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TYMP—esophageal cancer	9.57e-05	0.000272	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—esophageal cancer	9.52e-05	0.000271	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.31e-05	0.000265	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HIF1A—esophageal cancer	9.24e-05	0.000263	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1A—esophageal cancer	9.21e-05	0.000262	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.07e-05	0.000258	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KDR—esophageal cancer	8.84e-05	0.000251	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EP300—esophageal cancer	8.76e-05	0.000249	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTO1—esophageal cancer	8.65e-05	0.000246	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TPI1—esophageal cancer	8.65e-05	0.000246	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	8.32e-05	0.000237	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.3e-05	0.000236	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GAPDH—esophageal cancer	7.99e-05	0.000227	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CRABP1—esophageal cancer	7.92e-05	0.000225	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—esophageal cancer	7.63e-05	0.000217	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CREBBP—esophageal cancer	7.55e-05	0.000215	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GNG7—esophageal cancer	7.53e-05	0.000214	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—esophageal cancer	7.47e-05	0.000212	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.05e-05	0.000201	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—esophageal cancer	6.89e-05	0.000196	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOS3—esophageal cancer	6.76e-05	0.000192	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTT1—esophageal cancer	6.71e-05	0.000191	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP2A6—esophageal cancer	6.63e-05	0.000189	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PIK3CA—esophageal cancer	6.48e-05	0.000184	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB2—esophageal cancer	6.32e-05	0.00018	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.29e-05	0.000179	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENO1—esophageal cancer	6.29e-05	0.000179	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—esophageal cancer	6.27e-05	0.000178	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PSME2—esophageal cancer	6.2e-05	0.000176	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PSME1—esophageal cancer	6.2e-05	0.000176	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—esophageal cancer	5.58e-05	0.000159	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	5.4e-05	0.000154	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.35e-05	0.000152	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EP300—esophageal cancer	5.14e-05	0.000146	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.03e-05	0.000143	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.59e-05	0.00013	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—esophageal cancer	4.48e-05	0.000127	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.4e-05	0.000125	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—esophageal cancer	4.38e-05	0.000125	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	3.8e-05	0.000108	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—esophageal cancer	3.68e-05	0.000105	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.94e-05	8.36e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NOS3—esophageal cancer	2.63e-05	7.49e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.41e-05	6.85e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—EP300—esophageal cancer	2e-05	5.7e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.48e-05	4.21e-05	CbGpPWpGaD
